Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Interventional radiologist 1st in world to deliver newly approved cancer treatment
The completion of the first treatment represents a "significant milestone" for patients with liver cancer, the IR who led the procedure says.
Treatment-related cancers on the rise, new study suggests
Therapy-related acute myeloid leukemia is an aggressive form of blood cancer and bone marrow that occurs in the years following radiation and chemotherapy.
MRI-guided ablation as effective as surgery for prostate cancer treatment
A new clinical trial investigated the safety and efficacy of the procedure, along with its impact on urinary incontinence, erectile dysfunction and other factors.
AI-enabled lesion quantification tool earns new CPT code
The software gives clinicians detailed insight into how patients are responding to treatment based on changes in lesion size and metabolic activity, offering earlier opportunities to alter care plans.
One PSMA agent outshines competitors at detecting prostate cancer recurrence
An ongoing study is evaluating how capably two PSMA agents assess urinary radioactivity and identify smaller lesions in post-prostatectomy patients with low PSA biochemical recurrence.

Interventional radiologist 1st in world to deliver newly approved cancer treatment

The completion of the first treatment represents a "significant milestone" for patients with liver cancer, the IR who led the procedure says.

Therapy-related acute myeloid leukemia is an aggressive form of blood cancer and bone marrow that occurs in the years following radiation and chemotherapy.

MRI-guided ablation as effective as surgery for prostate cancer treatment

A new clinical trial investigated the safety and efficacy of the procedure, along with its impact on urinary incontinence, erectile dysfunction and other factors.

AI-enabled lesion quantification tool earns new CPT code

The software gives clinicians detailed insight into how patients are responding to treatment based on changes in lesion size and metabolic activity, offering earlier opportunities to alter care plans.

One PSMA agent outshines competitors at detecting prostate cancer recurrence

An ongoing study is evaluating how capably two PSMA agents assess urinary radioactivity and identify smaller lesions in post-prostatectomy patients with low PSA biochemical recurrence.

Drugmaker expands manufacturing of popular prostate PET imaging agent

The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.

University launches clinical trial for groundbreaking nuclear medicine cancer treatment

The University of Missouri Research Reactor will play a key role in the trial, as it is the only domestic producer of Y-90.

Photon-counting CT scans best conventional CTs for lung cancer follow-up

Photon-counting CT offers numerous benefits in lung cancer imaging

Compared to conventional contrast-enhanced chest computed tomography, photon-counting CT exams can reduce patients' effective radiation dose by more than 66%.